Article
Off-label evaluation of the BD MAX MDR-TB assay for rapid diagnosis of rifampicin and isoniazid resistance of<i>Mycobacterium tuberculosis</i>clinical isolates in a high-volume reference laboratory
2025-06-20
Abstract excerpt
Drug-resistant tuberculosis (TB) remains a major global health concern. Multidrug-resistant TB is defined by resistance to at least rifampicin (RIF) and isoniazid (INH), the two key drugs used in TB treatment. The BD MAX™ Multi-Drug Resistant Tuberculosis (BD MAX) assay is a fully automated real-time PCR platform, recommended by the World Health Organization for the initial diagnosis of TB and RIF and INH resistan...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- 36b8abad-68eb-5cbf-b60b-6460f16e17f1
- DOI
- 10.1101/2025.06.17.25329767